Main Meeting: The second annual meeting on Molecular Markers in Cancer, hosted by ASCO, NCI, and EORTC, will bring together clinicians, pathologists, researchers, and others to accelerate progress in the rapidly advancing field of cancer markers. Evidence-based cancer diagnosis and treatment depends increasingly on the development of new molecular markers for the assessment of prognosis, treatment selection, and agent development. This activity has been approved for AMA PRA Category 1 CreditTM.
Main meeting abstracts are now available.
Diagnostic Tutorial: Prior to the meeting, a 1½ day tutorial will address critical issues regarding new tools that aid clinical decision making and feature didactic presentations focused on issues raised in diagnostic challenges. Participants will work in teams to put together development plans for assays that will aid clinical decisions related to choice of therapy.
|
